New health basket committee finally named

Ben-Yizri approves the new public committee in charge of recommending which drugs and technologies will be included in the 2008 health services basket.

October 15, 2007 22:14
1 minute read.
New health basket committee finally named

medicines 88. (photo credit: )


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief


After months of delays, Health Minister Ya'acov Ben-Yizri received approval Monday from Finance Minister Ronnie Bar-On for the appointment of a new public committee to recommend which drugs and medical technologies will be included in the 2008 basket of health services. Drugs and services in the basket are provided to relevant patients by the four health funds, at Treasury expense. "I am aware of the fact that much time has passed between the time the previous committee finished its work and the appointment of the new committee," said Ben-Yizri, "but we can now say that careful and complex work has been done to find the most qualified representatives." No Treasury funding had been allocated to expand the 2007 basket, as the 2006 increase was twice the usual amount, but the new panel has around NIS 300 million to "spend" on new medications and technologies from among over NIS 1 billion worth of proposed drugs and technologies. The committee is supposed to make its recommendations on priorities to the Health Ministry before the end of December. The panel's new chairman is Prof. Menachem Fainaru, former dean of Tel Aviv University's Sackler School of Medicine and a senior medicine clinician. He replaces Prof. Mordechai Shani, a former Health Ministry and Sheba Medical Center director-general. Many of the committee members have not served before. The panel, which is to be coordinated by Dr. Osnat Luxemburg, is comprised of: former deputy defense minister Dalia Rabin-Pelosof; Rabbi Yuval Cherlow; Dr. Rahel Adatto (National Council for Women's Health); Prof. Adi Shani (National Oncology Council); Dr. Hezi Levi (new head of the Health Ministry's medical division); Dr. Yoram Blachar (chairman of the Israel Medical Association); Prof. Yehoshua Shemer (Maccabi Health Services); Dr. Andy Whiteman (Kupat Holim Leumit); Dr. Nicki Lieberman (Clalit Health Services); Dr. Ze'ev Abramson (Kupat Holim Meuhedet); Etti Semama (health system ombudsman); Prof. Noam Zohar (ethicist); and economists Reuven Kagan (Treasury); Iris Ginsburg (veteran pension funds); Yoel Lifschitz (a Health Ministry official who supervises health funds); and Ruth Ralbag (Health Ministry planning and budgets director).

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

[illustrative photo]
September 24, 2011
Diabetes may significantly increase risk of dementia